| Literature DB >> 34167836 |
Gregory A Poland1, Inna G Ovsyannikova2, Richard B Kennedy2.
Abstract
Entities:
Keywords: B-cell; COVID-19; Coronavirus; HLA class I; HLA class II; Immune response; Peptide; SARS-CoV-2; T-cell; Universal vaccine; Variant
Year: 2021 PMID: 34167836 DOI: 10.1016/j.vaccine.2021.06.028
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641